Shenzhen Henghui Charity Foundation (hereinafter referred to as “Henghui”) was established in May 2017 by Mr. Chen Xingjia, a former recipient of the CPC Central Committee’s honor as a “National Outstanding County Party Secretary.”
Henghui’s mission is: “Through innovative philanthropic practices, to explore and establish a social support system for vulnerable groups, and to promote the value of public welfare within the broader framework of social governance.” Guided by this mission, Henghui has launched innovative charitable projects in areas such as major illness relief, public health technology assessment, rural doctor training, youth mental health, and educational support.
In August 2017, Henghui spearheaded the “United Love Project”, a public welfare initiative focused on comprehensive control of childhood cancer. This project innovatively integrates four key dimensions: supplementary reimbursement through charitable medical insurance, standardized patient services, capacity-building for doctors in underdeveloped regions, and improvements in pharmaceutical policy. It aims to develop a systematic model for social forces to participate in major illness relief and explore long-term solutions to poverty caused by illness.
The project received official support from the Civil Affairs Bureau, the Health and Family Planning Bureau, and the Social Security Bureau of Heyuan City, Guangdong Province (Document No. 98 [2017] issued by Heyuan Civil Affairs Bureau). Over the past four years, the United Love Project has assisted 141 children with leukemia in Heyuan, and helped the People’s Hospital of Heyuan establish its first-ever pediatric hematology department.
Henghui also founded China’s first nonprofit Health Technology Assessment (HTA) Center, which functions as an independent third-party institution providing objective and evidence-based evaluations of medical services and pharmaceuticals. The center also offers HTA training programs and is building a national HTA data platform to support real-world medical research and establish a knowledge base for healthcare decision-making. This platform also contributes to standardizing real-world data governance and promoting the application of HTA across various sectors including government policy-making, health insurance, clinical practice, and patient decision-making.
Through its HTA efforts, Henghui has already helped two widely used innovative leukemia medications for children gain inclusion in China’s National Medical Insurance Catalog.
In 2019, the United Love Project was successfully replicated in Qinghai Province, where it provided assistance to 108 children with leukemia.
